SCHEMBL30777927

SCHEMBL30777927

CC(C)(C)OC(=O)NCCc1nc2c[n+]([O-])c3cc(Br)ccc3c2n1C1CCC1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
JAK1 P23458 8/20 0.40
JAK2 O60674 4/20 0.39
TYK2 P29597 3/20 0.39
JAK3 P52333 3/20 0.39
OPRM1 P35372 2/20 0.37
OPRD1 P41143 2/20 0.37
OGFRL1 Q5TC84 2/20 0.37
OPRK1 P41145 1/20 0.37
NQO2 P16083 1/20 0.35
GFER P55789 2/20 0.35
GNRHR P30968 1/20 0.35
ALDH1A1 P00352 1/20 0.35
CNR2 P34972 1/20 0.33
DYRK1A Q13627 1/20 0.33
PKM P14618 1/20 0.33
EGFR P00533 1/20 0.32
RAF1 P04049 1/20 0.32
KDR P35968 1/20 0.32
MAP2K2 P36507 1/20 0.32
MAP2K1 Q02750 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23910159 1.00 JAK1 (0.40) JAK1JAK2TYK2JAK3OPRM1
SCHEMBL21724877 0.84 JAK1 (0.50) JAK1JAK2TYK2JAK3OPRM1
SCHEMBL21724451 0.79 TLR7 (0.42) JAK1JAK2TYK2JAK3OPRM1
SCHEMBL23037671 0.75 NQO2 (0.39) NQO2GFERALDH1A1DYRK1AEGFR
SCHEMBL21724405 0.73 JAK2 (0.30) JAK1JAK2TYK2JAK3
SCHEMBL23037651 0.71 NQO2 (0.40) NQO2GFERALDH1A1
SCHEMBL21724518 0.70 JAK1 (0.53) JAK1JAK2TYK2JAK3
SCHEMBL23037626 0.69 GRM2 (0.35) NQO2DYRK1AEGFRRAF1KDR
SCHEMBL23037516 0.69 PDPK1 (0.40) NQO2DYRK1AEGFRRAF1KDR
SCHEMBL20475939 0.68 NLRP3 (0.41)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3837015-B1 IMIDAZO[4,5-C]QUINOLINE DERIVED NLRP3-MODULATORS INNATE TUMOR IMMUNITY INC (US) 2024-02-14 EP disclosed